Skip to main content
Erschienen in: Drugs & Aging 3/2007

01.03.2007 | Leading Article

How to Get Older People Included in Clinical Studies

verfasst von: Miles D. Witham, Professor Marion E. T. McMurdo

Erschienen in: Drugs & Aging | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Older people are systematically excluded from many clinical research studies. In this review, we examine the reasons for this state of affairs and summarise the current knowledge of strategies to increase the rate of participation of older people in clinical studies. Older people want to participate in clinical research and are driven by a mixture of altruism and self-interest. They are often excluded by overt age cut-offs or covert exclusions based on co-morbidity and frailty. Other barriers to participation include communication and cognitive difficulties, transport difficulties, low income and self-imposed agism. Possible strategies to improve recruitment of older people to clinical studies include abolishing age limits, reducing exclusion criteria, and allowing sufficient study time (to recruit and deal with older patients) and money (for reimbursement of their participation costs) in study protocols. Involving older people and their attending health professionals in the design of study protocols may also be helpful. Providing transportation, easy physical access to research institutions and use of personalised and face-to-face recruitment also pay dividends. A variety of recruitment methods have been found to be effective, but tailoring the strategy to the condition and population under study is necessary. Together, these strategies should improve the representation of older people in clinical research and ensure that the evidence base is relevant and useful to all those caring for older people.
Literatur
1.
Zurück zum Zitat Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–7PubMedCrossRef Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061–7PubMedCrossRef
2.
Zurück zum Zitat Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13PubMedCrossRef Lee PY, Alexander KP, Hammill BG, et al. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708–13PubMedCrossRef
3.
Zurück zum Zitat Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–7PubMedCrossRef Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250–7PubMedCrossRef
4.
Zurück zum Zitat Bandyopadhyay S, Bayer AJ, O’Mahony MS. Age and gender bias in statin trials. QJM 2001; 94: 127–32PubMedCrossRef Bandyopadhyay S, Bayer AJ, O’Mahony MS. Age and gender bias in statin trials. QJM 2001; 94: 127–32PubMedCrossRef
5.
Zurück zum Zitat Gill SS, Bronskill SE, Mamdani M, et al. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol 2004; 11: e274–85PubMed Gill SS, Bronskill SE, Mamdani M, et al. Representation of patients with dementia in clinical trials of donepezil. Can J Clin Pharmacol 2004; 11: e274–85PubMed
6.
Zurück zum Zitat Schneider LS, Olin JT, Lyness SA, et al. Eligibility of Alzheimer’s disease clinic patients for clinical trials. J Am Geriatr Soc 1997; 45: 923–8PubMed Schneider LS, Olin JT, Lyness SA, et al. Eligibility of Alzheimer’s disease clinic patients for clinical trials. J Am Geriatr Soc 1997; 45: 923–8PubMed
7.
Zurück zum Zitat Rochon PA, Fortin PR, Dear KB, et al. Reporting of age data in clinical trials of arthritis: deficiencies and solutions. Arch Intern Med 1993; 153: 243–8PubMedCrossRef Rochon PA, Fortin PR, Dear KB, et al. Reporting of age data in clinical trials of arthritis: deficiencies and solutions. Arch Intern Med 1993; 153: 243–8PubMedCrossRef
8.
Zurück zum Zitat Mitchell SL, Sullivan EA, Lipsitz LA. Exclusion of elderly subjects from clinical trials for Parkinson disease. Arch Neurol 1997; 54: 1393–8PubMedCrossRef Mitchell SL, Sullivan EA, Lipsitz LA. Exclusion of elderly subjects from clinical trials for Parkinson disease. Arch Neurol 1997; 54: 1393–8PubMedCrossRef
9.
Zurück zum Zitat Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ 2000; 321: 992–3PubMedCrossRef Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ 2000; 321: 992–3PubMedCrossRef
10.
Zurück zum Zitat Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315: 1059PubMedCrossRef Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315: 1059PubMedCrossRef
11.
Zurück zum Zitat McMurdo ME, Witham MD, Gillespie ND. Including older people in clinical research. BMJ 2005; 331: 1036–7PubMedCrossRef McMurdo ME, Witham MD, Gillespie ND. Including older people in clinical research. BMJ 2005; 331: 1036–7PubMedCrossRef
12.
Zurück zum Zitat Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 2005; 9: iii–x, 1PubMed Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 2005; 9: iii–x, 1PubMed
13.
Zurück zum Zitat Wei L, Ebrahim S, Bartlett C, et al. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 2005; 330: 821PubMedCrossRef Wei L, Ebrahim S, Bartlett C, et al. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 2005; 330: 821PubMedCrossRef
14.
Zurück zum Zitat Witham MD, Gillespie ND, Struthers AD. Tolerability of spironolactone in patients with chronic heart failure: a cautionary message. Br J Clin Pharmacol 2004; 58: 554–7PubMedCrossRef Witham MD, Gillespie ND, Struthers AD. Tolerability of spironolactone in patients with chronic heart failure: a cautionary message. Br J Clin Pharmacol 2004; 58: 554–7PubMedCrossRef
15.
Zurück zum Zitat Ferguson PR. Selecting participants when testing new drugs: the implications of age and gender discrimination. Med Leg J 2002; 70: 130–4PubMedCrossRef Ferguson PR. Selecting participants when testing new drugs: the implications of age and gender discrimination. Med Leg J 2002; 70: 130–4PubMedCrossRef
16.
Zurück zum Zitat Peterson ED, Lytle BL, Biswas MS, et al. Willingness to participate in cardiac trials. Am J Geriatr Cardiol 2004; 13: 11–5PubMedCrossRef Peterson ED, Lytle BL, Biswas MS, et al. Willingness to participate in cardiac trials. Am J Geriatr Cardiol 2004; 13: 11–5PubMedCrossRef
17.
Zurück zum Zitat Comis RL, Miller JD, Aldige CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003; 21: 830–5PubMedCrossRef Comis RL, Miller JD, Aldige CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003; 21: 830–5PubMedCrossRef
18.
Zurück zum Zitat Yuval R, Uziel K, Gordon N, et al. Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients’ perspective. Eur J Heart Fail 2001; 3: 217–23PubMedCrossRef Yuval R, Uziel K, Gordon N, et al. Perceived benefit after participating in positive or negative/neutral heart failure trials: the patients’ perspective. Eur J Heart Fail 2001; 3: 217–23PubMedCrossRef
19.
Zurück zum Zitat Schron EB, Wassertheil-Smoller S, Pressel S. Clinical trial participant satisfaction: survey of SHEP enrollees. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc 1997; 45: 934–8PubMed Schron EB, Wassertheil-Smoller S, Pressel S. Clinical trial participant satisfaction: survey of SHEP enrollees. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc 1997; 45: 934–8PubMed
20.
Zurück zum Zitat Townsley CA, Chan KK, Pond GR, et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006; 6: 34PubMedCrossRef Townsley CA, Chan KK, Pond GR, et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006; 6: 34PubMedCrossRef
21.
Zurück zum Zitat Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383–9PubMedCrossRef Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383–9PubMedCrossRef
22.
Zurück zum Zitat Avenell A, Grant AM, McGee M, et al. The effects of an open design on trial participant recruitment, compliance and retention: a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin Trials 2004; 1: 490–8PubMedCrossRef Avenell A, Grant AM, McGee M, et al. The effects of an open design on trial participant recruitment, compliance and retention: a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin Trials 2004; 1: 490–8PubMedCrossRef
23.
Zurück zum Zitat Welton AJ, Vickers MR, Cooper JA, et al. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ 1999; 318: 1114–7PubMedCrossRef Welton AJ, Vickers MR, Cooper JA, et al. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ 1999; 318: 1114–7PubMedCrossRef
24.
Zurück zum Zitat Whelton PK, Bahnson J, Appel LJ, et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). J Am Geriatr Soc 1997; 45: 185–93PubMed Whelton PK, Bahnson J, Appel LJ, et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). J Am Geriatr Soc 1997; 45: 185–93PubMed
25.
Zurück zum Zitat Gorkin L, Schron EB, Handshaw K, et al. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials 1996; 17: 46–59PubMedCrossRef Gorkin L, Schron EB, Handshaw K, et al. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials 1996; 17: 46–59PubMedCrossRef
26.
Zurück zum Zitat Chang BH, Hendricks AM, Slawsky MT, et al. Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure. BMC Med Res Methodol 2004; 4: 8PubMedCrossRef Chang BH, Hendricks AM, Slawsky MT, et al. Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure. BMC Med Res Methodol 2004; 4: 8PubMedCrossRef
27.
Zurück zum Zitat Allsup SJ, Gosney MA. Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people. Gerontology 2002; 48: 170–3PubMedCrossRef Allsup SJ, Gosney MA. Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people. Gerontology 2002; 48: 170–3PubMedCrossRef
28.
Zurück zum Zitat Tolmie EP, Mungall MM, Louden G, et al. Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants. Age Ageing 2004; 33: 374–8PubMedCrossRef Tolmie EP, Mungall MM, Louden G, et al. Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants. Age Ageing 2004; 33: 374–8PubMedCrossRef
29.
Zurück zum Zitat Unson CG, Dunbar N, Curry L, et al. The effects of knowledge, attitudes, and significant others on decisions to enroll in a clinical trial on osteoporosis: implications for recruitment of older African-American women. J Natl Med Assoc 2001; 93: 392–401PubMed Unson CG, Dunbar N, Curry L, et al. The effects of knowledge, attitudes, and significant others on decisions to enroll in a clinical trial on osteoporosis: implications for recruitment of older African-American women. J Natl Med Assoc 2001; 93: 392–401PubMed
30.
Zurück zum Zitat Mills N, Donovan JL, Smith M, et al. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials 2003; 24: 272–82PubMedCrossRef Mills N, Donovan JL, Smith M, et al. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials 2003; 24: 272–82PubMedCrossRef
31.
Zurück zum Zitat Gross CP, Filardo G, Mayne ST, et al. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 2005; 103: 483–91PubMedCrossRef Gross CP, Filardo G, Mayne ST, et al. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 2005; 103: 483–91PubMedCrossRef
32.
Zurück zum Zitat Unger JM, Coltman CA Jr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006; 24: 141–4PubMedCrossRef Unger JM, Coltman CA Jr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006; 24: 141–4PubMedCrossRef
33.
Zurück zum Zitat Gross CP, Wong N, Dubin JA, et al. Enrollment of older persons in cancer trials after the medicare reimbursement policy change. Arch Intern Med 2005; 165: 1514–20PubMedCrossRef Gross CP, Wong N, Dubin JA, et al. Enrollment of older persons in cancer trials after the medicare reimbursement policy change. Arch Intern Med 2005; 165: 1514–20PubMedCrossRef
34.
Zurück zum Zitat Gross CP, Herrin J, Wong N, et al. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol 2005; 23: 4755–63PubMedCrossRef Gross CP, Herrin J, Wong N, et al. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol 2005; 23: 4755–63PubMedCrossRef
35.
Zurück zum Zitat Hewison J, Haines A. Overcoming barriers to recruitment in health research. BMJ 2006; 333: 300–2PubMedCrossRef Hewison J, Haines A. Overcoming barriers to recruitment in health research. BMJ 2006; 333: 300–2PubMedCrossRef
36.
Zurück zum Zitat Crombie IK, Irvine L, McMurdo MET, et al. Overcoming barriers to recruitment in health research: concerns of potential participants need to be dealt with. BMJ 2006 Aug 19; 333(7564): 398PubMedCrossRef Crombie IK, Irvine L, McMurdo MET, et al. Overcoming barriers to recruitment in health research: concerns of potential participants need to be dealt with. BMJ 2006 Aug 19; 333(7564): 398PubMedCrossRef
37.
Zurück zum Zitat Street A, Strong J, Karp S. Improving patient recruitment to multicentre clinical trials: the case for employing a data manager in a district general hospital-based oncology centre. Clin Oncol (R Coll Radiol) 2001; 13: 38–43 Street A, Strong J, Karp S. Improving patient recruitment to multicentre clinical trials: the case for employing a data manager in a district general hospital-based oncology centre. Clin Oncol (R Coll Radiol) 2001; 13: 38–43
38.
Zurück zum Zitat Rahman M, Morita S, Fukui T, et al. Physicians’ reasons for not entering their patients in a randomized controlled trial in Japan. Tohoku J Exp Med 2004; 203: 105–9PubMedCrossRef Rahman M, Morita S, Fukui T, et al. Physicians’ reasons for not entering their patients in a randomized controlled trial in Japan. Tohoku J Exp Med 2004; 203: 105–9PubMedCrossRef
39.
Zurück zum Zitat Peto V, Coulter A, Bond A. Factors affecting general practitioners’ recruitment of patients into a prospective study. Fam Pract 1993; 10: 207–11PubMedCrossRef Peto V, Coulter A, Bond A. Factors affecting general practitioners’ recruitment of patients into a prospective study. Fam Pract 1993; 10: 207–11PubMedCrossRef
40.
Zurück zum Zitat Ford ME, Havstad SL, Davis SD. A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2004; 1: 343–51PubMedCrossRef Ford ME, Havstad SL, Davis SD. A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2004; 1: 343–51PubMedCrossRef
41.
Zurück zum Zitat Simpson NK, Johnson CC, Ogden SL, et al. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials 2000; 21(6 Suppl.): 356S–78SPubMedCrossRef Simpson NK, Johnson CC, Ogden SL, et al. Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials 2000; 21(6 Suppl.): 356S–78SPubMedCrossRef
42.
Zurück zum Zitat Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ 2002; 325: 415PubMedCrossRef Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ 2002; 325: 415PubMedCrossRef
43.
Zurück zum Zitat Unson CG, Ohannessian C, Kenyon L, et al. Strategies for enrolling diverse older women in an osteoporosis trial. J Aging Health 2004; 16: 669–87PubMedCrossRef Unson CG, Ohannessian C, Kenyon L, et al. Strategies for enrolling diverse older women in an osteoporosis trial. J Aging Health 2004; 16: 669–87PubMedCrossRef
44.
Zurück zum Zitat Donovan J, Mills N, Smith M, et al. Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ 2002; 325: 766–70PubMedCrossRef Donovan J, Mills N, Smith M, et al. Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult. BMJ 2002; 325: 766–70PubMedCrossRef
45.
Zurück zum Zitat Cambron JA. Recruitment and accrual of women in a randomized controlled trial of spinal manipulation. J Manipulative Physiol Ther 2001; 24: 79–83PubMedCrossRef Cambron JA. Recruitment and accrual of women in a randomized controlled trial of spinal manipulation. J Manipulative Physiol Ther 2001; 24: 79–83PubMedCrossRef
46.
Zurück zum Zitat Adams J, Silverman M, Musa D, et al. Recruiting older adults for clinical trials. Control Clin Trials 1997; 18: 14–26PubMedCrossRef Adams J, Silverman M, Musa D, et al. Recruiting older adults for clinical trials. Control Clin Trials 1997; 18: 14–26PubMedCrossRef
47.
Zurück zum Zitat Haibert JA, Silagy CA, Finucane P, et al. Recruitment of older adults for a randomized, controlled trial of exercise advice in a general practice setting. J Am Geriatr Soc 1999; 47: 477–81 Haibert JA, Silagy CA, Finucane P, et al. Recruitment of older adults for a randomized, controlled trial of exercise advice in a general practice setting. J Am Geriatr Soc 1999; 47: 477–81
48.
Zurück zum Zitat Groupp E, Haas M, Fairweather A, et al. Recruiting seniors with chronic low back pain for a randomized controlled trial of a self-management program. J Manipulative Physiol Ther 2005; 28: 97–102PubMedCrossRef Groupp E, Haas M, Fairweather A, et al. Recruiting seniors with chronic low back pain for a randomized controlled trial of a self-management program. J Manipulative Physiol Ther 2005; 28: 97–102PubMedCrossRef
49.
Zurück zum Zitat Coleman EA, Tyll L, LaCroix AZ, et al. Recruiting African-American older adults for a community-based health promotion intervention: which strategies are effective? Am J Prev Med 1997; 13: 51–6PubMed Coleman EA, Tyll L, LaCroix AZ, et al. Recruiting African-American older adults for a community-based health promotion intervention: which strategies are effective? Am J Prev Med 1997; 13: 51–6PubMed
50.
Zurück zum Zitat Flicker L, Wark JD. Recruitment strategies for randomised clinical trials in elderly Australians. Med J Aust 1997; 167: 438–9PubMed Flicker L, Wark JD. Recruitment strategies for randomised clinical trials in elderly Australians. Med J Aust 1997; 167: 438–9PubMed
51.
Zurück zum Zitat Pressel S, Davis BR, Louis GT, et al. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Control Clin Trials 2001; 22: 674–86PubMedCrossRef Pressel S, Davis BR, Louis GT, et al. Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Control Clin Trials 2001; 22: 674–86PubMedCrossRef
52.
Zurück zum Zitat Norton MC, Breitner JC, Welsh KA, et al. Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc 1994; 42: 1252–6PubMed Norton MC, Breitner JC, Welsh KA, et al. Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc 1994; 42: 1252–6PubMed
53.
Zurück zum Zitat Zhu K, Hunter S, Bernard LJ, et al. Recruiting elderly African-American women in cancer prevention and control studies: a multifaceted approach and its effectiveness. J Natl Med Assoc 2000; 92: 169–75PubMed Zhu K, Hunter S, Bernard LJ, et al. Recruiting elderly African-American women in cancer prevention and control studies: a multifaceted approach and its effectiveness. J Natl Med Assoc 2000; 92: 169–75PubMed
54.
Zurück zum Zitat Kushler MG, Davidson WS. Alternative modes of outreach: an experimental comparison. Gerontologist 1978; 18: 355–62PubMedCrossRef Kushler MG, Davidson WS. Alternative modes of outreach: an experimental comparison. Gerontologist 1978; 18: 355–62PubMedCrossRef
55.
Zurück zum Zitat Sellors J, Cosby R, Trim K, et al. Recruiting family physicians and patients for a clinical trial: lessons learned. Fam Pract 2002; 19: 99–104PubMedCrossRef Sellors J, Cosby R, Trim K, et al. Recruiting family physicians and patients for a clinical trial: lessons learned. Fam Pract 2002; 19: 99–104PubMedCrossRef
56.
Zurück zum Zitat Silagy CA, Campion K, McNeil JJ, et al. Comparison of recruitment strategies for a large-scale clinical trial in the elderly. J Clin Epidemiol 1991; 44: 1105–14PubMedCrossRef Silagy CA, Campion K, McNeil JJ, et al. Comparison of recruitment strategies for a large-scale clinical trial in the elderly. J Clin Epidemiol 1991; 44: 1105–14PubMedCrossRef
57.
Zurück zum Zitat Ory MG, Lipman PD, Karlen PL, et al. Recruitment of older participants in frailty/injury prevention studies. Prev Sci 2002; 3: 1–22PubMedCrossRef Ory MG, Lipman PD, Karlen PL, et al. Recruitment of older participants in frailty/injury prevention studies. Prev Sci 2002; 3: 1–22PubMedCrossRef
58.
Zurück zum Zitat Donovan JL, Peters TJ, Noble S, et al. Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol 2003; 56: 605–9PubMedCrossRef Donovan JL, Peters TJ, Noble S, et al. Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). J Clin Epidemiol 2003; 56: 605–9PubMedCrossRef
59.
Zurück zum Zitat Moorman PG, Newman B, Millikan RC, et al. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999; 9: 188–95PubMedCrossRef Moorman PG, Newman B, Millikan RC, et al. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999; 9: 188–95PubMedCrossRef
60.
Zurück zum Zitat Levkoff S, Sanchez H. Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion. Gerontologist 2003; 43: 18–26PubMedCrossRef Levkoff S, Sanchez H. Lessons learned about minority recruitment and retention from the Centers on Minority Aging and Health Promotion. Gerontologist 2003; 43: 18–26PubMedCrossRef
61.
Zurück zum Zitat Gregson BA, Smith M, Lecouturier J, et al. Issues of recruitment and maintaining high response rates in a longitudinal study of older hospital patients in England: pathways through care study. J Epidemiol Community Health 1997; 51: 541–8PubMedCrossRef Gregson BA, Smith M, Lecouturier J, et al. Issues of recruitment and maintaining high response rates in a longitudinal study of older hospital patients in England: pathways through care study. J Epidemiol Community Health 1997; 51: 541–8PubMedCrossRef
62.
Zurück zum Zitat Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist 2003; 43: 62–72PubMedCrossRef Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist 2003; 43: 62–72PubMedCrossRef
Metadaten
Titel
How to Get Older People Included in Clinical Studies
verfasst von
Miles D. Witham
Professor Marion E. T. McMurdo
Publikationsdatum
01.03.2007
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 3/2007
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200724030-00002

Weitere Artikel der Ausgabe 3/2007

Drugs & Aging 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.